中国循证医学杂志 2012, 12(6): 679~685
论 著

二次研究
多巴胺与去甲肾上腺素治疗感染性休克疗效比较的系统评价
赵 阳1 王 倩2 臧 彬1*
1. 中国医科大学附属盛京医院ICU(沈阳 110004);2. 中国医科大学附属第四医院急诊科(沈阳 110032)
摘要 目的 系统评价多巴胺与去甲肾上腺素治疗感染性休克的疗效及安全性。方法 计算机检索MEDLINE、EMbase、Cochrane图书馆、VIP、CNKI、CBM和WanFang Data等数据库(检索时限均从建库至2011年6月),纳入所有使用多巴胺或去甲肾上腺素治疗感染性休克的随机对照试验(RCT)。评价纳入研究的方法学质量和提取有效数据后,采用RevMan 5.1软件进行Meta分析。结果 共纳入9个RCT,3 179例休克患者。Meta分析结果显示:多巴胺同去甲肾上腺素相比,能使感染性休克患者住院期间死亡风险增加12%,其差异具有统计学意义[RR=1.12,95%CI(1.04,1.21),P=0.002];多巴胺组感染性休克患者心率失常事件发生风险是去甲肾上腺素组的2.63倍[RR=2.63,95%CI(1.51,4.55),P=0.000 6];多巴胺组心脏指数较去甲肾上腺素组增加[MD=0.42,95%CI(0.21,0.63),P<0.000 1];但在心率[MD=17.05,95%CI(–0.71,34.81),P=0.06]及平均动脉压[MD= –0.87,95%CI(–24.97,7.62),P=0.30]方面,两组差异无统计学意义。结论 去甲肾上腺素同多巴胺相比能显著降低感染性休克患者住院期间死亡率,降低心律失常事件的发生率,其疗效及安全性优于多巴胺。
关键词 多巴胺;去甲肾上腺素;感染性休克;随机对照试验;系统评价;Meta分析
Dopamine versus Norepinephrine for Septic Shock: A Systemic Review
ZHAO Yang1, WANG Qian2, ZANG Bin1*
1. Department of ICU, Shengjing Hospital Affi liated to China Medical University, Shenyang 110004, China;
th
2. Department of Emergency, the 4 Hospital Affi liated to China Medical University, Shenyang 110032, China
Abstract Objective To systemically review the efficacy and safety of dopamine versus norepinephrine in pa-tients with septic shock. Methods Database searches of MEDLINE, EMbase, Cochrane Controlled Trials Register, VIP, CNKI, and CBM (from the date of database establishment to June 2011) were conducted. Additional studies for collect-ing relevant data were retrieved via both references of articles and direct contact with authors. Prospectively, randomized controlled trials (RCTs) of dopamine compared with norepinephrine therapy in septic shock patients were selected. Th e quality of included trials was assessed and relevant data were extracted. Th en statistical analysis was performed using Rev-Man 5.1. Results Nine trials with 3 179 participants were included. Th e results of meta-analysis showed: compared with norepinephrine, dopamine was associated with a signifi cant 12% elevation in the risk ratio of in-hospital death events of septic shock patients (RR=1.12, 95%CI 1.04 to 1.21, P=0.002). Th e risk of arrhythmias in dopamine group was 2.63-fold than that in norepinephrine group (RR=2.63, 95%CI 1.51 to 4.55, P=0.000 6). Th e cardiac index of septic patients in dopamine group was higher than that in norepinephrine group (MD=0.42, 95%CI 0.21 to 0.63, P<0.000 1). No signifi cant diff erence could be found in the heart rate (MD=17.05, 95%CI –0.71 to 34.81, P=0.06) and mean arterial pressure (MD= –0.87, 95%CI –24.97 to 7.62, P=0.30). Conclusion Findings from this meta-analysis suggest that compared with dopa-mine, norepinephrine signifi cantly reduces both 28-day mortality of septic shock patients and incidence rate of arrhyth-mias. Norepinephrine is better than dopamine in aspects of effi cacy and safety.
Key words Dopamine; Norepinephrine; Septic shock; Randomized controlled trial; Systemic review; Meta-analysis
脓毒血症和感染性休克的发病率逐年增加,二
作者简介:赵阳,男(1986年~),硕士,中国医科大学附属盛京医院ICU住院医师,以重症感染诊治为主要研究方向。Email: z2003y2002@126.com
* 通讯作者,Email: zangbin_66@126.com
者均是导致重症监护病房(ICU)患者死亡的重要原血管加压素用于经过充足的液体复苏,血压因 [1]。
仍低于正常范围的感染性休克患者,多巴胺和去甲肾上腺素作为纠正感染性休克患者低血压的一线用但多巴胺和去甲肾上腺素哪个药已被指南推荐 [2]。
CJEBM
679
© 2012 中国循证医学杂志编辑部doc.guandang.net
本系统评价通过收集国内外所有关于多巴胺及 去甲肾上腺素治疗感染性休克的临床随机对照试验 数据, 比较多巴胺和去甲肾上腺素对感染性休克患 者住院期间病死率的...
暂无评价0人阅读0次下载举报文档 多巴胺和去甲肾上腺素治疗感染性休克的比较_医药卫生_专业资料。ICU中治疗常用药物的认识今日推荐 四...
多巴胺与去甲肾上腺素治疗心源性休克的疗效比较 目的比较多巴胺与去甲肾上腺素两种药物治疗心源性休克的疗效。方法将51例心源性休克患者分为多巴胺组与去甲肾上腺...
目的比较去甲肾上腺素和多巴胺对感染性休克的复苏效果。方法将50例感染性休克患者随机分为观察组和对照组各25例,观察组采用去甲肾上腺素治疗,对照组应用多巴胺...
暂无评价
暂无评价0人阅读0次下载举报文档Comparison of Dopamine and Norepinephrine in Treatment of Shock 多巴胺和去甲肾上腺素治疗休克的比较 李瑞杰 ? ? ? ? ?...
方法 将 50 例感染性休克患者随机 分为观察组和对照组各 25 例,观察组采用去甲肾上腺素治疗,对照组应用多巴胺治疗,比较分析两组的复苏 效果。 结果 观察组的...
多巴胺和去甲肾上腺素在感染性休克的应用和疗效的再评价2_基础医学_医药卫生_专业资料。多巴胺和去甲肾上腺素在感染性休克的应用和疗效的再评价多...
热门文档